The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Azole Antifungal Resistance Today: Focus on Aspergillus
Abstract
Oral triazole therapy is well established for the treatment of invasive aspergillosis (IPA), allergic aspergillosis (ABPA), and chronic pulmonary aspergillosis (CPA), and is often long-term. Resistance to triazole azole antifungal drugs in Aspergillus fumigatus is now a major clinical problem in a number of European locations, in China, Canada and the USA with particularly high frequencies from the north-west of the UK, and The Netherlands. A number of centers are reporting the continuing increasing frequency and evolution of resistance mechanisms in A. fumigatus, in both azole-naïve and patients treated with azoles. The increasing rate of resistance is of concern. A number of resistance mechanisms have been found. The biofilm modality of Aspergillus growth may have a number of therapeutic implications for aspergillosis, including antifungal resistance. Microbiological diagnosis of aspergillosis is limited by poor culture yield, leading to uncertainty about the frequency of triazole resistance. Direct resistance testing in culture-negative clinical samples may add additional insights into the prevalence of azole resistance in A. fumigatus.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Members from Acremonium, Aspergillus, Cladosporium, Fusarium, and Pneumocystis, in addition to Candida, are among the biofilm formers tested for drug susceptibility in vitro.
“These include (in addition to Candida) members from Acremonium, Aspergillus, Cladosporium, Fusarium, and Pneumocystis (9, 20, 35, 42, 79, 160, 176).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [20]
Cells in biofilms have been found to be more resistant to drugs compared with cells grown in suspension culture.
“For example, a number of these biofilm formers (Table 3) have been tested for drug susceptibility in vitro, and cells in biofilms have been found to be more resistant to drugs compared with cells grown in suspension culture.”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [20]
Citations
Cites
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 880
The link between fungi and severe asthma: A summary of the evidence
Denning, D. W., O'Driscoll, B. R., Hogaboam, C. M., Bowyer, P., & Niven, R. M. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00074705 · Cited by 824
Self-citationHoward, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750
Self-citationAzole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?
Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., & Melchers, W. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70265-8 · Cited by 604
Itraconazole resistance in Aspergillus fumigatus
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 507
Self-citationOur Current Understanding of Fungal Biofilms
Ramage, G., Mowat, E., Jones, B., Williams, C., & Lopez-Ribot, J. (2009) · Critical Reviews in Microbiology · doi:10.3109/10408410903241436 · Cited by 483
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma
Smith, N. L., & Denning, D. W. (2011) · European Respiratory Journal · doi:10.1183/09031936.00054810 · Cited by 449
Self-citationAzole antifungal resistance in Aspergillus fumigatus: 2008 and 2009
Bueid, A. S., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., & Denning, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq279 · Cited by 333
Self-citationDenning, D. W., Park, S., Lass-Florl, C., Fraczek, M. G., Kirwan, M., Gore, R., Smith, J., Bueid, A., Moore, C. B., Bowyer, P., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir179 · Cited by 313
Self-citationdo Nascimento, A. M., Goldman, G. H., Park, S., Marras, S. A. E., Delmas, G., Oza, U., Lolans, K., Dudley, M. N., Mann, P. A., & Perlin, D. S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1719-1726.2003 · Cited by 256
Slaven, J. W., Anderson, M. J., Sanglard, D., Dixon, G. K., Bille, J., Roberts, I. S., & Denning, D. W. (2002) · Fungal Genetics and Biology · doi:10.1016/s1087-1845(02)00016-6 · Cited by 202
Self-citationMortensen, K. L., Hare, R. K., Johansen, H. K., Skov, M., Pressler, T., Howard, S. J., Leatherbarrow, H., Mellado, E., & Arendrup, M. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00213-11 · Cited by 179
Azole Resistance of Aspergillus fumigatus Biofilms Is Partly Associated with Efflux Pump Activity
Rajendran, R., Mowat, E., McCulloch, E., Lappin, D. F., Jones, B., Lang, S., Majithiya, J. B., Warn, P. A., Williams, C., & Ramage, G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01189-10 · Cited by 157
Development of resistance in candida isolates from patients receiving prolonged antifungal therapy
Fan‐Havard, P., Capano, D., Smith, S. M., Mangia, A., & Eng, R. H. K. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.11.2302 · Cited by 152
Ferreira, M. E. D. S., Capellaro, J. L., Marques, E. D. R., Malavazi, I., Perlin, D. S., Park, S., Anderson, J. B., Colombo, A. L., Arthington, B. A., Goldman, M. H. S., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4405-4413.2004 · Cited by 147
Cryptic Species and Azole Resistance in the Aspergillus niger Complex
Howard, S. J., Harrison, E., Bowyer, P., Varga, J., & Denning, D. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00304-11 · Cited by 138
Self-citationAspergillus fumigatus biofilms in the clinical setting
Müller, F.-M. C., Seidler, M., & Beauvais, A. (2011) · Medical Mycology · doi:10.3109/13693786.2010.502190 · Cited by 123
Oakley, K. L., Morrissey, G., & Denning, D. W. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1504 · Cited by 109
Self-citationVerweij, P. E., Dorsthorst, D. T. A. T., Rijs, A. J. M. M., de Vries-Hospers, H. G., & Meis, J. F. G. M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2648-2650.2002 · Cited by 108
Snelders, E., Melchers, W. J. G., & Verweij, P. E. (2011) · Future Microbiology · doi:10.2217/fmb.11.4 · Cited by 98
Osherov, N. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.75 · Cited by 96
Multidrug Resistance inAspergillus fumigatus
Warris, A., Weemaes, C. M. R., & Verweij, P. E. (2002) · New England Journal of Medicine · doi:10.1056/nejm200212263472618 · Cited by 86
Richardson, M. D., & Warnock, D. W. (2012) · Wiley eBooks · doi:10.1002/9781118321492 · Cited by 78
Self-citationMosquera, J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf111 · Cited by 77
Pasqualotto, A. C., POWELL, G., Niven, R. M., & Denning, D. W. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01640.x · Cited by 77
Self-citationSiikala, E., Rautemaa, R., Richardson, M., Saxen, H., Bowyer, P., & Sanglard, D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq354 · Cited by 66
Self-citationRautemaa‐Richardson, R., Richardson, M. D., Pfaller, M. A., Koukila-Kähkölä, P., Perheentupa, J., & Saxén, H. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm299 · Cited by 59
Self-citationMODIFIED RESPONSE TO KETOCONAZOLE OF CANDIDA ALBICANS FROM A TREATMENT FAILURE
Warnock, D. W., Johnson, E. M., Richardson, M. D., & Vickers, C. F. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91809-3 · Cited by 57
Self-citationHeald, A. E., Cox, G. M., Schell, W. A., Bartlett, J. A., & Perfect, J. R. (1996) · AIDS · doi:10.1097/00002030-199603000-00004 · Cited by 54
In-vivo itraconazole resistance of Aspergillus fumigatus in systemic murine aspergillosis
Dannaoui, É., Borel, E., Persat, F., Monier, M., Piens, M. A., & Ebga Network (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-12-1087 · Cited by 47
Manavathu, E. K., Abraham, O. C., & Chandrasekar, P. H. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2001.00220.x · Cited by 43
Fungal pneumonia in patients with hematologic malignancies
Mulanovich, V. E., & Kontoyiannis, D. P. (2011) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3283486d1d · Cited by 20
Flagged first, then by citations
Cited by
Sorted by citations
Candida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Chowdhary, A., Kathuria, S., Xu, J., & Meis, J. F. G. M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003633 · Cited by 383
Predictors of mortality in chronic pulmonary aspergillosis
Lowes, D., Al-Shair, K., Newton, P. J., Morris, J., Harris, C., Rautemaa-Richardson, R., & Denning, D. W. (2017) · European Respiratory Journal · doi:10.1183/13993003.01062-2016 · Cited by 194
Self-citationTriazole Resistance in Aspergillus Species: An Emerging Problem
Garcia‐Rubio, R., Cuenca‐Estrella, M., & Mellado, E. (2017) · Drugs · doi:10.1007/s40265-017-0714-4 · Cited by 162
Smith, J. A., & Kauffman, C. A. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02150.x · Cited by 151
Current status of antifungal resistance and its impact on clinical practice
Alcázar‐Fuoli, L., & Mellado, E. (2014) · British Journal of Haematology · doi:10.1111/bjh.12896 · Cited by 118
A Review of Onychomycosis Due to Aspergillus Species
Bongomin, F., Batac, M. C. F. R., Richardson, M. D., & Denning, D. W. (2017) · Mycopathologia · doi:10.1007/s11046-017-0222-9 · Cited by 108
Self-citationTreatment options in severe fungal asthma and allergic bronchopulmonary aspergillosis
Moss, R. B. (2013) · European Respiratory Journal · doi:10.1183/09031936.00139513 · Cited by 95
High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates
Buied, A., Moore, C. B., Denning, D. W., & Bowyer, P. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks451 · Cited by 88
Self-citationEnvironmental fungicides and triazole resistance in Aspergillus
Bowyer, P., & Denning, D. W. (2013) · Pest Management Science · doi:10.1002/ps.3567 · Cited by 87
Self-citationChowdhary, A., Kathuria, S., Xu, J., & Meis, J. F. G. M. (2013) · PLoS Pathogens · doi:10.1371/annotation/4ffcf1da-b180-4149-834c-9c723c5dbf9b · Cited by 85
Meneau, I., Coste, A. T., & Sanglard, D. (2016) · Medical Mycology · doi:10.1093/mmy/myw005 · Cited by 80
Wei, X., Chen, P., Gao, R., Li, Y., Zhang, A., Liu, F., & Lü, L. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02101-16 · Cited by 75
Melo, A. M., Stevens, D. A., Tell, L. A., Veríssimo, C., Sabino, R., & Xavier, M. O. (2020) · Microorganisms · doi:10.3390/microorganisms8122037 · Cited by 68
Fungal Biofilms: Update on Resistance
Borghi, E., Borgo, F., & Morace, G. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_7 · Cited by 69
Jensen, R. H., Hagen, F., Astvad, K. M. T., Tyron, A., Meis, J. F. G. M., & Arendrup, M. C. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.04.001 · Cited by 60
Krishnan Natesan, S., Wu, W., Cutright, J. L., & Chandrasekar, P. H. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.06.030 · Cited by 58
N -Myristoyltransferase Is a Cell Wall Target in Aspergillus fumigatus
Fang, W., Robinson, D. A., Raimi, O. G., Blair, D. E., Harrison, J. R., Lockhart, D. E. A., Torrie, L. S., Ruda, G. F., Wyatt, P. G., Gilbert, I. H., et al. (2015) · ACS Chemical Biology · doi:10.1021/cb5008647 · Cited by 47
An invertebrate model to evaluate virulence in Aspergillus fumigatus: The role of azole resistance
Gómez‐López, A., Forastiero, A., Cendejas‐Bueno, E., Gregson, L., Mellado, E., Howard, S. J., Livermore, J., Hope, W. W., & Cuenca‐Estrella, M. (2014) · Medical Mycology · doi:10.1093/mmy/myt022 · Cited by 46
Exploring the molecular mechanism of azole resistance in Aspergillus fumigatus
Chen, P., Liu, J., Zeng, M., & Sang, H. (2019) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2019.100915 · Cited by 44
Bassetti, M., Vena, A., Bouza, E., Peghin, M., Muñoz, P., Righi, E., Pea, F., Lackner, M., & Lass-Flörl, C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.017 · Cited by 40
In VitroBiochemical Study of CYP51-Mediated Azole Resistance in Aspergillus fumigatus
Warrilow, A. G. S., Parker, J. E., Price, C. L., Nes, W. D., Kelly, S. L., & Kelly, D. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01806-15 · Cited by 38
Fitness Studies of Azole-Resistant Strains of Aspergillus fumigatus
Valsecchi, I., Mellado, E., Beau, R., Raj, S., & Latgé, J. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01594-15 · Cited by 37
Understanding the environmental drivers of clinical azole resistance in Aspergillus species
Sen, P., Vijay, M., Singh, S., Hameed, S., & Vijayaraghavan, P. (2022) · Drug Target Insights · doi:10.33393/dti.2022.2476 · Cited by 37
Gandhi, J., Suthar, D. D., Patel, H., Shelat, P., & Parejiya, P. B. (2020) · Oriental Pharmacy and Experimental Medicine · doi:10.1007/s13596-020-00462-6 · Cited by 30
Current and Future Challenges in the Development of Antimicrobial Agents
Rennie, R. P. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-28951-4_4 · Cited by 30
Uncovering New Mutations Conferring Azole Resistance in the Aspergillus fumigatus cyp51A Gene
Chen, P., Liu, M., Zeng, Q., Zhang, Z., Liu, W., Sang, H., & Lü, L. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03127 · Cited by 30
The impact of azole resistance on aspergillosis guidelines
Georgiadou, S. P., & Kontoyiannis, D. P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06795.x · Cited by 25
Azole resistance among clinical isolates of Aspergillus fumigatus in Lima-Peru
Bustamante, B., Illescas, L. R., Posadas, A., & Campos, P. E. (2019) · Medical Mycology · doi:10.1093/mmy/myz032 · Cited by 25
Design, synthesis & evaluation of condensed 2H-4-arylaminopyrimidines as novel antifungal agents
Jain, K. S., Khedkar, V. M., Arya, N., Rane, P. V., Chaskar, P. K., & Coutinho, E. C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.066 · Cited by 22
van de Peppel, R. J., Dekkers, O. M., Borne, P. A. V. D., & de Boer, M. G. J. (2014) · Medical Mycology · doi:10.1093/mmy/myu036 · Cited by 22
Role of carbonic anhydrases in pathogenic micro-organisms: a focus on Aspergillus fumigatus
Tobal, J. M., & Ferreira, M. E. D. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.064444-0 · Cited by 21
Paul, S. K., & Moye-Rowley, S. (2013) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2013.06.004 · Cited by 17
Camplesi, M., Silva, H. M. E., Arantes, A. D. M., Costa, C. R., Ataídes, F. S., Silva, T. C., Reis, M. P. D. C., & Silva, M. D. R. R. (2017) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0191-2016 · Cited by 15
van der Torre, M. H., Whitby, C., Eades, C. P., Moore, C. B., Frazer, L. N., Richardson, M. D., & Rautemaa‐Richardson, R. (2020) · Journal of Fungi · doi:10.3390/jof6040208 · Cited by 8
Self-citationUpdate on Antifungal Resistance and its Clinical Impact
Posteraro, B., Posteraro, P., & Sanguinetti, M. (2013) · Current Fungal Infection Reports · doi:10.1007/s12281-013-0143-0 · Cited by 5
Furnica, D.-T., Dittmer, S., Sanders, M. I., Steinmann, J., Rath, P., & Kirchhoff, L. (2022) · Journal of Fungi · doi:10.3390/jof8040350 · Cited by 5
Synergy between azoles and 1,4-dihydropyridine derivative as an option to control fungal infections
Ježíková, Z., Pagáč, T., Pfeiferová, B., Bujdáková, H., Dižová, S., Jančíková, I., Gášková, D., & Olejníková, P. (2017) · Antonie van Leeuwenhoek · doi:10.1007/s10482-017-0895-6 · Cited by 5
Antifungal Efficacy of Plant Essential Oils Against Candida, Aspergillus and Cryptococcus Species
Kumari, K. M. U., Imam, M. W., & Luqman, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_5 · Cited by 4
Gandhi, J., Suthar, D. D., Patel, H., Shelat, P., & Parejiya, P. J. (2020) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2020.120214 · Cited by 4
Pulmonary aspergillosis: diagnosis and treatment
Quereshi, S., Paralikar, P., Pandit, R., Razzaghi‐Abyaneh, M., Kon, K. V., & Rai, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-804543-5.00012-9 · Cited by 3
Wang, X., Yusufu, A., Hasimu, H., & Abliz, P. (2024) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2024.0002 · Cited by 3
Vazquez, M. A., Garcia, S., ARMENDARIZ, K., Villaseñor-Granados, T. O., Ponce‐Noyola, P., Flores, A., Martínez-Álvarez, J. A., Garcia-Revilla, M. A., Robles, J., & Alcaraz‐Contreras, Y. (2019) · Journal of the Mexican Chemical Society · doi:10.29356/jmcs.v63i2.751 · Cited by 3
Recent Advancements in Combinational Antifungal Therapy and Immunotherapy
Rathore, S. S., Ramakrishnan, J., & Raman, T. (2016) · Springer eBooks · doi:10.1007/978-81-322-2782-3_6 · Cited by 1
Metadata
- Authors
- Bowyer, P., Moore, C. B., Rautemaa, R., Denning, D. W., & Richardson, M. D.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- Corresponding author
- Richardson, Malcolm D.
- Venue
- Current Infectious Disease Reports
- Published
- 2011-09-20
- Volume
- 13
- Issue
- 6
- Pages
- 485-491
- ISSN
- 1523-3847 (ISSN-L)
- 1534-3146
- OpenAlex
- W2070897511
- Cited by
- 44
- References
- 32
- Citations by year
- 2024: 2 · 2022: 2 · 2020: 6 · 2019: 3 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 4 · 2013: 7 · 2012: 5
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Current Infectious Disease Reports (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- azole resistance, triazole resistance, Aspergillus fumigatus, invasive aspergillosis, allergic bronchopulmonary aspergillosis, chronic pulmonary aspergillosis, antifungal resistance mechanisms, biofilm formation, resistance testing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review